일리노이의 주요우울장애 임상 시험
주요우울장애 관련 연구 20개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.
일리노이의 도시
공식 연구 텍스트(영어)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Charter Research - Chicago, Chicago
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Chicago Research Center, Chicago
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Northwestern University, Chicago
- Baber Research Group, Naperville
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Chicago Research Center, Chicago
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Endeavor Health Evanston Hospital, Evanston
피험자 모집 중3상
12세 ~ 17세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Rush University, Chicago
피험자 모집 중3상
18세 ~ 85세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Chicago
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Advanced Quality Medical Research, Orland Park
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Chicago
- Draig Clinical Site, Skokie
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Rush University Medical Center, Chicago
피험자 모집 중
22세 ~ 70세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06423430A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Uptown Research Institute, Chicago
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07592689A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- EmVenio Research, Chicago
피험자 모집 중2상
18세 ~ 64세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Chicago
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
- Amr Conventions Research /ID# 277547, Warrenville
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT07276997Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
피험자 모집 중
18세 ~ 64세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT05051618A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research LLC, Chicago
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 5. 11. 업데이트됨 · NCT06524830Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
피험자 모집 중관찰 연구
18세 ~ 40세 · 모든 성별 · 2026. 3. 10. 업데이트됨 · NCT06740383Study of ALTO-300 in MDD
- Site 310, Chicago
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2025. 7. 24. 업데이트됨 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Chicago
피험자 모집 중4상
18세 ~ 65세 · 모든 성별 · 2025. 1. 23. 업데이트됨 · NCT06223880ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.